Co-Enrolment

Co-Enrolment 

Find below a list of trials VITDALIZE UK can co-enrol with. 

It includes interventional trials which have formally agreed to co-enrolment with VITDALIZE UK. These trials have been considered by their respective trial management groups prior to sign off by their Chief Investigators. 

This process has taken into consideration any potential issues regarding:

    • Study design and statistical considerations
    • Biological and scientific considerations
    • Possible drug interactions and any additional safety reporting
    • Implications of co-enrolment on participants and their relatives
    • Legal and ethical issues
    • Logical and organisational considerations

It also includes observational studies approved by the VITDALIZE UK Chief Investigator and Trial Management Group. 

Trials that can co-enrol with VITDALIZE: 

    • ABC
    • ADAPT-SEPSIS
    • AKI Aftercare 
    • AspiFlu
    • ASPECT
    • ASTOP
    • BSRBR-RA
    • CandiRes
    • CHEST
    • CIRCA
    • COVID-TRACHE
    •  CPS 
    • DIAMONDS
    • EMERALD
    • EFFORT
    • EPICTETUS
    • Gen OMICC
    • GOLDILOCS
    • FLO-ELA
    • iCareWean
    • IMPACT
    • ISARIC
    • iRehab
    • MARCH
    • MAST
    • Mec-Rox 
    • MICAH
    • MOSSAIC
    • ORIF
    • P25/30
    • PHIND
    • PQIP
    • PREFIBRILLATE
    • Recovery RS
    • Red Diamond
    • REVISE
    • ROSSINI-2
    • SCRIPT
    • SINFONIA
    • SHORTER 
    • SOS
    • Threshold for Platelets (T4P)
    • UK-ROX
    • VAPx
    • VESPER
    • VITAL 

Trials where co-enrolment is not permitted: 

    • A2B
    • ANNEXA-RS
    • CHIP-BCIS3
    • EXALT
    • Octreotide 
    • UNIVERSAL 
    • POP-I
    • RECOVERY
    • REMAP CAP
    • REVIVAL
    • SEAL

If you have any further queries or wish to discuss additional trials, please contact the VITDALIZE UK trial team.